News
BLCO
16.56
-0.42%
-0.07
Is COO Stock Attractive as MyDay Gains Meet Asia-Pacific Pressure
NASDAQ · 4h ago
How COO Is Balancing Premium Lens Growth Against Asia-Pacific Risks?
NASDAQ · 4h ago
3 Small-Cap Stocks We Steer Clear Of
Barchart · 17h ago
Weekly Report: what happened at BLCO last week (0622-0626)?
Weekly Report · 1d ago
Weekly Report: what happened at BLCO last week (0615-0619)?
Weekly Report · 06/22 10:02
Weekly Report: what happened at BLCO last week (0608-0612)?
Weekly Report · 06/15 10:03
Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock?
NASDAQ · 06/10 10:36
Assessing Bausch + Lomb (NYSE:BLCO) Valuation After Blink Triple Care Preservative Free U.S. Launch
Simply Wall St · 06/08 14:18
Weekly Report: what happened at BLCO last week (0601-0605)?
Weekly Report · 06/08 10:00
Will Blink Triple Care’s Preservative Free Launch Reshape Bausch + Lomb’s (BLCO) Consumer Eye Care Narrative?
Simply Wall St · 06/07 00:24
Bausch + Lomb’s New Dry Eye Launch And What It Means For BLCO
Simply Wall St · 06/05 20:22
Where short sellers are betting across mid- and large-cap stocks
Seeking Alpha · 06/04 13:35
Most and least shorted mid- to mega-cap healthcare stocks at the end of May
Seeking Alpha · 06/03 13:35
Weekly Report: what happened at BLCO last week (0525-0529)?
Weekly Report · 06/01 10:03
Assessing Bausch + Lomb (NYSE:BLCO) Valuation After Recent Share Price Weakness And Governance Concerns
Simply Wall St · 06/01 04:27
Bausch + Lomb: Even Though Growth Continues, I Don't See A Way Higher
Seeking Alpha · 05/26 14:28
Weekly Report: what happened at BLCO last week (0518-0522)?
Weekly Report · 05/25 10:06
Bausch + Lomb Corporation (BLCO) Receives a Hold from Stifel Nicolaus
TipRanks · 05/21 13:56
Stocks in play: Bausch + Lomb Corporation
Barchart · 05/21 10:47
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Barchart · 05/21 06:15
More
Webull provides a variety of real-time BLCO stock news. You can receive the latest news about Bausch + Lomb Corporation through multiple platforms. This information may help you make smarter investment decisions.
About BLCO
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.